# Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis

> **NCT05329116** · NA · UNKNOWN · sponsor: **Necmettin Yildiz** · enrollment: 42 (estimated)

## Conditions studied

- Osteo Arthritis Knee

## Interventions

- **DRUG:** Lidocaine 2% Injectable Solution
- **BIOLOGICAL:** Platelet-rich plasma

## Key facts

- **NCT ID:** NCT05329116
- **Lead sponsor:** Necmettin Yildiz
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-15
- **Primary completion:** 2022-10-25
- **Final completion:** 2022-12-25
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05329116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05329116, "Efficacy of Mesotherapy Added to Intra-articular Platelet-rich Plasma (PRP) in Patients With Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05329116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*